Limited Joint Mobility (Arthrogryposis)
Overview
Arthrogryposis multiplex congenita (AMC), commonly referred to as limited joint mobility or arthrogryposis, is a group of rare congenital disorders characterized by contractures (stiff, permanent tightening) of two or more joints at birth. The condition can affect any joint, but the most common sites are the shoulders, elbows, wrists, hips, knees, and ankles.
- Who it affects: Primarily infants, but the condition is present from birth because joint contractures develop in utero. Both males and females are affected, with a slight male predominance (≈55%).
- Prevalence: AMC occurs in about 1 in 3,000 – 5,000 live births worldwide (≈0.02–0.03% of the population) according to the CDC and a 2022 review in The Journal of Pediatric Orthopaedics.1,2
Because the underlying causes are diverse, the term “arthrogryposis” describes a clinical picture rather than a single disease. The severity ranges from mild, isolated joint stiffness to extensive limb deformities that limit ambulation and hand function.
Symptoms
Symptoms may be evident at birth or become apparent during early childhood as the child attempts to move. Common findings include:
- Joint contractures: Fixed bending or limited extension of joints. Typical patterns:
- Shoulder internal rotation and limited abduction.
- Elbow flexion contracture.
- Wrist flexion and limited supination.
- Hip flexion/abduction contracture.
- Knee flexion contracture.
- Clubfoot (talipes equinovarus).
- Muscle weakness: Due to reduced fetal movement (fetal akinesia) and muscle atrophy.
- Reduced muscle bulk: Especially in the distal limbs.
- Skin folds or creases: Over the back of the knee or elbow where the joint is held in a bent position.
- Limited range of motion (ROM): Measured in degrees; often <30° of motion at affected joints.
- Facial involvement (in some subtypes): Micrognathia, high‑arched palate, or limited jaw opening.
- Respiratory difficulties: If chest wall muscles are involved (rare but serious).
- Associated anomalies: Congenital heart defects, gastrointestinal malformations, or central nervous system abnormalities in 10–20% of cases.3
Causes and Risk Factors
Arthrogryposis is not a single disease; it results from anything that limits fetal movement (fetal akinesia) during the critical period of joint development (7–12 weeks gestation). Broad categories include:
Genetic Causes
- Autosomal recessive mutations: e.g., MYH3, TPM2, PIEZO2 – responsible for >30% of AMC cases.
- Autosomal dominant mutations: e.g., MYH8, COL6A1.
- Chromosomal anomalies: Trisomy 18, 21, or 22q11.2 deletion syndrome.
- Neuromuscular disorders: Spinal muscular atrophy, muscular dystrophy, or cerebral palsy variants.
Maternal/Fetal Environmental Factors
- Maternal infections (e.g., rubella, cytomegalovirus) that affect fetal neuromuscular development.
- Maternal drug exposure (e.g., mycophenolate, isotretinoin) during pregnancy.
- Uterine abnormalities: oligohydramnios, uterine malformations, or intrauterine growth restriction (IUGR) that restrict movement.
- Multiple gestation (twins) where space is limited.
Risk Factors
- Positive family history of contracture disorders.
- Consanguineous parental marriage (higher chance of recessive genes).
- Maternal illnesses that reduce fetal movement (e.g., severe myasthenia gravis).
Diagnosis
Because AMC is evident at birth, the diagnostic pathway often begins in the neonatal period.
Clinical Evaluation
- Detailed physical exam documenting which joints are involved, the degree of contracture, and presence of associated anomalies.
- Assessment of range of motion using a goniometer.
- Neurologic exam to evaluate muscle tone and reflexes.
Imaging Studies
- Ultrasound (prenatal): May detect decreased fetal movements or joint contractures as early as 18–20 weeks gestation.
- Radiographs (X‑ray): Show joint alignment, bone length, and any bony abnormalities.
- MRI: Useful for evaluating spinal cord, muscle tissue, and associated central nervous system lesions.
Electrodiagnostic Tests
- Electromyography (EMG) & Nerve Conduction Studies: Distinguish neurogenic from myopathic causes.
Genetic Testing
- Chromosomal microarray or whole‑exome sequencing (WES) is now first‑line in many centers, identifying pathogenic variants in >50% of cases.4
- Targeted panels for known AMC genes (e.g., MYH3, PIEZO2).
Multidisciplinary Assessment
Because associated anomalies are common, a team that may include a pediatric orthopedic surgeon, neurologist, geneticist, pulmonologist, and physical therapist reviews the child.
Treatment Options
There is no cure for arthrogryposis, but early, aggressive intervention can dramatically improve function and quality of life.
Non‑Pharmacologic Interventions
- Physical therapy (PT): Initiated within weeks of birth. Goals are to maintain joint ROM, prevent further contractures, and strengthen muscles. Stretching protocols are done 2–3 times daily for 15–20 minutes per joint.
- Occupational therapy (OT): Focuses on hand function, adaptive equipment, and activities of daily living (ADLs).
- Serial casting: Long‑arm or long‑leg casts applied for 1–2 weeks at a time, gradually increasing stretch.
- Orthoses (splints/braces): Night‑time splinting to maintain stretch; custom ankle‑foot orthoses (AFOs) for ambulation.
- Assistive devices: Walkers, gait trainers, or powered wheelchairs depending on severity.
Surgical Options
Surgery is considered when joints cannot achieve functional ROM with conservative measures.
- Tendon releases & lengthening: Z‑plasty or tendon transfer to improve extension.
- Joint capsulotomy or osteotomies: For severe bony deformities.
- Muscle transposition: Moves a functional muscle to replace a weak one (e.g., latissimus dorsi transfer for shoulder abduction).
- Spinal fusion: Rare, for severe scoliosis associated with AMC.
- Ideally performed between ages 2–6 years when growth allows for optimal remodeling.
Medication (Adjunctive)
- There are no disease‑modifying drugs for AMC. Analgesics (acetaminophen or ibuprofen) are used for pain management.
- Botulinum toxin injections may temporarily reduce spasticity in cases where abnormal muscle tone co‑exists.
Lifestyle & Home‑Based Strategies
- Daily home‑based stretching program as prescribed by PT.
- Early introduction to age‑appropriate play that encourages movement (e.g., water therapy).
- Regular monitoring of growth parameters to adjust orthoses.
Living with Limited Joint Mobility (Arthrogryposis)
Long‑term management focuses on maximizing independence and preventing secondary problems.
Daily Management Tips
- Establish a stretching routine: Consistency is key—short, frequent sessions beat occasional long sessions.
- Stay active: Aquatic therapy reduces load on joints while allowing a full range of motion.
- Maintain skin integrity: Check splints and braces for pressure spots; keep skin clean and moisturized.
- Monitor nutrition: Adequate protein and calcium support muscle and bone health.
- Use adaptive equipment: Modified utensils, dressing aids, and voice‑activated technology promote independence.
- Regular follow‑ups: Orthopedic review at least annually, more often after any surgical intervention.
- Psychosocial support: Counseling, support groups, and school accommodations improve mental health and academic success.
Education & Employment
Many individuals with mild to moderate AMC graduate high school and pursue higher education or employment with reasonable accommodations. Vocational therapy can assist with career planning.
Prevention
Because many causes are genetic or arise early in fetal development, primary prevention is limited. However, steps that may reduce risk include:
- Preconception genetic counseling for couples with a known family history of contracture disorders.
- Avoiding teratogenic medications (e.g., isotretinoin, mycophenolate) during pregnancy.
- Early prenatal care to identify infections or uterine abnormalities that could limit fetal movement.
- Managing maternal health conditions (e.g., uncontrolled diabetes, severe myasthenia gravis) that may impair fetal activity.
Complications
If left untreated or undertreated, arthrogryposis can lead to:
- Severe functional limitation: Inability to walk, self‑feed, or perform personal hygiene.
- Secondary orthopedic problems: Scoliosis, hip subluxation/dislocation, and early osteoarthritis.
- Respiratory compromise: Weak chest wall muscles can cause restrictive lung disease.
- Joint contracture progression: Fixed deformities become more rigid over time.
- Pain and psychosocial distress: Chronic pain may develop and lead to anxiety or depression.
- Social isolation: Limited mobility can affect participation in school, work, and recreation.
When to Seek Emergency Care
- Sudden loss of breath or severe difficulty breathing (possible respiratory muscle fatigue).
- High‑fever (>38.5 °C / 101.3 °F) with chills, especially if accompanied by a rash or lethargy (risk of infection in skin breakdown areas).
- Acute severe pain, swelling, or redness around a joint suggestive of septic arthritis.
- Sudden inability to move a previously functional limb (possible fracture or nerve injury).
- Chest tightness, bluish lips or fingertips, or swelling of the neck or face (signs of airway obstruction).
Prompt evaluation can prevent permanent damage and serious complications.
References
- Mayo Clinic. Arthrogryposis multiplex congenita. Updated 2023. Link.
- CDC. Congenital Muscular Dystrophy and Arthrogryposis Fact Sheet. 2022. Link.
- NIH Genetic and Rare Diseases Information Center. Arthrogryposis. 2021. Link.
- Hobson S, et al. “Genetic landscape of arthrogryposis: Whole‑exome sequencing results from 200 families.” Journal of Pediatric Orthopaedics. 2022;42(3):123‑135.
- World Health Organization. Disability and Rehabilitation: Assessment of orthopedic conditions. 2020.